7,612
edits
Changes
Jump to navigation
Jump to search
Prize Fund for HIV/AIDS Act (view source)
Revision as of 17:26, 14 March 2017
, 17:26, 14 March 2017no edit summary
Return to [[Innovation Policy#Patent Reform | Patent Reform]]. The [[Prize System for Inventions|Prize Fund ]] for HIV/AIDS Act is a [http://www.edegan.com/wiki/index.php/Patent_Reform#Legislation_Considered_in_Previous_Congressional_Sessions patent reform act] proposed in a previous congressional session.See: https://www.congress.gov/bill/112th-congress/senate-bill/1138
==Summary==
The act nullifies patents on manufacturing processes of drugs, so that no company may hold the patent on the manufacturing process of a drug. However, a company becomes eligible for prize funds by holding a patent on the manufacturing process they use to create a drug. [Bill language: ''...in the case of a manufacturing process for a qualifying treatment for HIV/AIDS, the holder of the patent with respect to such process...'']. No new firms may be eligible for prize funds if they use a manufacturing process they did not hold a patent for.
[[Category: Public]]
[[Public Classification::Legislation| ]]
